Matrixyl 10% + HA

There is a version of skincare where anti-aging means retinoids, and retinoids mean redness, peeling, and a two-month adjustment period that tests your commitment to the cause. Then there is Matrixyl. No adjustment period. No irritation. No purging. No pregnancy restrictions. Just peptides, quietly doing their work beneath a layer of moisturizer while you go about your life entirely unbothered.

The Ordinary's Matrixyl 10% + HA has been part of the brand's lineup since its 2016 launch, and in many ways it embodies the DECIEM thesis more purely than any other product in the range. Matrixyl — a trade name developed by Sederma, the French cosmetic ingredient company now owned by BASF — had been a prestige ingredient for years, licensed to brands that sold peptide serums for 0, 20, sometimes 00. The Ordinary put it in a 0.90 bottle at 10% concentration and let the ingredient speak for itself.

The formula contains two Matrixyl generations. Matrixyl 3000 combines Palmitoyl Tripeptide-1 and Palmitoyl Tetrapeptide-7 — two peptides that work on opposite sides of the collagen equation. Tripeptide-1 is a matrikine, a signaling peptide that tells fibroblasts to produce new collagen as if they were repairing micro-damage. Tetrapeptide-7 reduces interleukin-6 secretion, an inflammatory cytokine that drives collagen degradation. One peptide pushes production up. The other pushes breakdown down. The combination, in manufacturer-funded clinical trials, reduced wrinkle area by 44% and wrinkle density by 37% over two months of twice-daily application.

Matrixyl Synthe'6, the second generation, goes broader. Palmitoyl Tripeptide-38 signals the production of six different extracellular matrix components simultaneously: collagen I, III, and IV, fibronectin, hyaluronic acid, and laminin 5. This is not just collagen stimulation — it is a comprehensive matrix repair signal. The skin's structural integrity depends on the interplay between all these components, and Synthe'6 addresses the scaffold as a system rather than targeting one protein in isolation.

The 10% concentration is worth appreciating in context. Many peptide serums list Matrixyl or its components on their INCI but at concentrations well below the levels used in clinical studies. At 10% of the total formula by weight, The Ordinary is delivering a genuinely generous dose. The peptides are dissolved in an aqueous base of glycerin and sodium hyaluronate, which provides immediate surface hydration and helps stabilize the peptides in a skin-compatible pH range of 5.0-6.0.

On the skin, this serum applies as a clear, slightly viscous liquid with a faint tackiness from the hyaluronic acid. It is not unpleasant, but if you have strong preferences about serum texture, you will notice it for the first two to three minutes before it absorbs. Once a moisturizer goes on top, the tackiness vanishes completely. There is no tingling, no warmth, no sensation at all — which is exactly what a peptide serum should feel like. Peptides work through cellular signaling, not through the kind of chemical activity that produces sensory feedback.

The timeline for results is where expectations need careful calibration. Peptides do not work like retinoids. There is no dramatic peeling phase followed by revealed baby-smooth skin. There is no purging period where things look worse before they look better. Instead, there is a slow, incremental improvement that builds over weeks and months. By week four, skin may feel slightly firmer and more hydrated — partly from the HA, partly from the early effects of increased collagen synthesis. By week eight to twelve, fine lines around the eyes and forehead begin to soften in a way that is easier to measure than to perceive in the mirror. By month three to six, the cumulative improvement becomes genuinely visible, particularly in before-and-after photographs.

This gradual nature is both the product's strength and its PR problem. Plenty of users have posted reviews saying some variation of "I used it for a month and I am not sure it did anything." Peptide results are not designed to be dramatic — they are designed to be sustainable. The collagen you build with consistent peptide use accumulates over time, and the anti-inflammatory effects of Tetrapeptide-7 help preserve what you build. It is investment-grade skincare: unglamorous in the short term, genuinely valuable over years.

The pregnancy-safe profile is a significant practical advantage. Retinoids — the other major category of collagen-stimulating actives — are contraindicated during pregnancy and breastfeeding. Matrixyl peptides carry no such restriction. For anyone who is pregnant, trying to conceive, or breastfeeding and wants to maintain an anti-aging routine, this product fills a gap that very few others can.

The conflict list is the main practical limitation. Peptides are hydrolyzed by low-pH environments, which means Matrixyl cannot be used in the same routine as glycolic acid, salicylic acid, L-ascorbic acid, or other direct acids. If your anti-aging strategy relies on vitamin C in the morning, you will need to use Matrixyl at night — or choose a vitamin C derivative that operates at a higher pH. For routines that already include retinoids and acids, fitting Matrixyl in requires some scheduling.

At 0.90 for a 30 mL bottle that lasts two to three months with twice-daily use, the annual cost of Matrixyl therapy is approximately 4-66. For context, department store peptide serums with lower Matrixyl concentrations regularly sell for 0-150 per bottle. The math is not subtle, and it is one of the most compelling arguments for The Ordinary's approach to skincare: that premium ingredients, at generous concentrations, do not require premium pricing.

Formula

The Science

The Matrixyl peptide complexes in this formula operate through matrikine signaling — the process by which peptide fragments of extracellular matrix proteins signal cells to synthesize new matrix components. This mechanism was first characterized for the original Matrixyl (palmitoyl pentapeptide-4, or pal-KTTKS), a fragment of type I collagen that Robinson et al. demonstrated could improve photoaged facial skin in a 2005 study published in the International Journal of Cosmetic Science.

Matrixyl 3000 advances this concept with two complementary peptides. Palmitoyl Tripeptide-1 activates collagen synthesis through TGF-beta signaling, while Palmitoyl Tetrapeptide-7 reduces IL-6 secretion in keratinocytes — an inflammatory mediator that accelerates matrix metalloproteinase (MMP) activity and collagen degradation. In Sederma's randomized, double-blind clinical study on 24 volunteers, twice-daily application of Matrixyl 3000 for 56 days produced a 44% reduction in deep wrinkle area, 37% reduction in wrinkle density, and measurable improvements in skin tone and elasticity.

Matrixyl Synthe'6 (Palmitoyl Tripeptide-38) represents a broader approach. Rather than targeting collagen alone, it signals the upregulation of six matrix components — collagen types I, III, and IV, fibronectin, laminin 5, and hyaluronic acid. This comprehensive matrix repair addresses the dermal-epidermal junction (collagen IV and laminin 5), the structural dermis (collagen I and III), the extracellular scaffolding (fibronectin), and the hydration matrix (hyaluronic acid) simultaneously. Raab et al. (Journal of Cosmetic Dermatology, 2020) demonstrated that a serum containing Palmitoyl Tripeptide-38 produced measurable improvements in wrinkle features after 56 days in a study of 35 women.

The palmitoyl conjugation of all three peptides is pharmacologically significant. The palmitic acid chain enhances lipophilicity, facilitating penetration through the lipid-rich stratum corneum that would otherwise be impermeable to free peptides. This delivery strategy — attaching a lipid anchor to a hydrophilic signaling peptide — has been validated across multiple cosmetic peptide studies.

References

1. Topical palmitoyl pentapeptide provides improvement in photoaged human facial skin — International Journal of Cosmetic Science (2005)
2. A serum containing vitamins C & E and a matrix-repair tripeptide reduces facial signs of aging — Journal of Cosmetic Dermatology (2020)

Dermatologist Perspective

Dermatologists view peptide serums as a useful complement to — rather than a replacement for — retinoids in anti-aging regimens. Board-certified dermatologists note that Matrixyl peptides work through a different mechanism than retinoids (matrikine signaling vs. retinoid receptor activation), making them additive rather than redundant when used together. The pregnancy-safe profile makes Matrixyl one of the most commonly recommended anti-aging actives for pregnant and breastfeeding patients. Dermatologists caution that peptide results are more subtle and gradual than retinoid results, and set expectations accordingly — this is maintenance and prevention, not dramatic reversal. The 10% concentration in this product is considered generous by dermatological standards, and the conflict-free profile (except with acids) makes it easy to integrate into existing treatment plans.

Guidance

Matrixyl 10% + HA was one of approximately ten products in The Ordinary's debut lineup in 2016, and it represented the brand's ambition perfectly: a premium peptide complex that had previously been available only in 00+ serums, offered at 0.90. The Matrixyl name itself was developed by Sederma (now part of BASF), and the peptides have been licensed to hundreds of skincare brands — but few use them at this concentration, and fewer still price them this aggressively.

About The Ordinary Established Brand (5–20 years)

The Ordinary launched under DECIEM in 2016 and rapidly became the most disruptive force in skincare by offering clinical-grade actives at unprecedented price points. Now owned by Estée Lauder Companies, the brand has built nearly a decade of consumer trust through ingredient transparency and accessible pricing.

Brand founded: 2016 · Product launched: 2016

Myth vs. Reality

Myth

Peptides do not actually penetrate the skin and are therefore useless

Reality

While large proteins cannot penetrate the stratum corneum, the Matrixyl peptides in this formula are small, lipid-conjugated (palmitoylated) peptides specifically designed for skin penetration. The palmitoyl chain acts as a delivery vehicle, anchoring the peptide to skin lipids and facilitating transport. Clinical studies using these specific peptides have demonstrated measurable changes in wrinkle depth and collagen markers.

Myth

You can use peptides with acids in the same routine for maximum anti-aging

Reality

Low-pH environments cause peptide hydrolysis — literally breaking the bonds between amino acids that give peptides their function. Using Matrixyl with glycolic acid, L-ascorbic acid, or other direct acids in the same routine degrades the peptides before they can work. Separate them into AM and PM routines, or alternate days, for full benefit from both.

FAQ

Common Praise

"Exceptional value for a 10% peptide serum — comparable products cost 0-150"

"Noticeable softening of fine lines around eyes and forehead within 4-8 weeks"

"Lightweight texture layers easily under other products without pilling"

"Extremely gentle — suitable for sensitive skin and pregnancy-safe"

"Hydrating HA base provides immediate plumping while peptides work long-term"

Common Complaints

"Slight tackiness on application that takes a few minutes to resolve"

"Results are gradual and subtle — difficult to perceive without before/after photos"

"Some users report small whiteheads, possibly from butylene glycol"

"Only available in 30 mL with no larger value size"

"Cannot be combined with acids or vitamin C in the same routine"

Appears In

best peptide serum best anti aging serum budget best the ordinary products best pregnancy safe anti aging best serum for fine lines

Related Conditions

aging dullness texture dehydration

Related Ingredients

peptides hyaluronic acid glycerin